Mercator Medical Sa Stock Net Income

MM2 Stock  EUR 9.49  0.03  0.32%   
As of the 8th of February, Mercator Medical secures the Downside Deviation of 0.8638, risk adjusted performance of 0.029, and Mean Deviation of 0.7836. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mercator Medical, as well as the relationship between them. Please verify Mercator Medical information ratio, treynor ratio, value at risk, as well as the relationship between the jensen alpha and maximum drawdown to decide if Mercator Medical SA is priced some-what accurately, providing market reflects its recent price of 9.49 per share.
Mercator Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Mercator Medical's valuation are provided below:
Mercator Medical SA does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
Understanding that Mercator Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mercator Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Mercator Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

Mercator Medical 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mercator Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mercator Medical.
0.00
11/10/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/08/2026
0.00
If you would invest  0.00  in Mercator Medical on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding Mercator Medical SA or generate 0.0% return on investment in Mercator Medical over 90 days. Mercator Medical is related to or competes with Chesapeake Utilities, Canlan Ice, United Utilities, Transport International, SPORTING, and PARKEN Sport. Mercator Medical is entity of Germany. It is traded as Stock on F exchange. More

Mercator Medical Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mercator Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mercator Medical SA upside and downside potential and time the market with a certain degree of confidence.

Mercator Medical Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Mercator Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mercator Medical's standard deviation. In reality, there are many statistical measures that can use Mercator Medical historical prices to predict the future Mercator Medical's volatility.
Hype
Prediction
LowEstimatedHigh
8.329.4910.66
Details
Intrinsic
Valuation
LowRealHigh
7.788.9510.12
Details

Mercator Medical February 8, 2026 Technical Indicators

Mercator Medical Backtested Returns

At this point, Mercator Medical is not too volatile. Mercator Medical has Sharpe Ratio of 0.0462, which conveys that the firm had a 0.0462 % return per unit of risk over the last 3 months. We have found twenty-six technical indicators for Mercator Medical, which you can use to evaluate the volatility of the firm. Please verify Mercator Medical's Downside Deviation of 0.8638, mean deviation of 0.7836, and Risk Adjusted Performance of 0.029 to check out if the risk estimate we provide is consistent with the expected return of 0.054%. Mercator Medical has a performance score of 3 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.0925, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Mercator Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Mercator Medical is expected to be smaller as well. Mercator Medical right now secures a risk of 1.17%. Please verify Mercator Medical SA treynor ratio, value at risk, and the relationship between the sortino ratio and maximum drawdown , to decide if Mercator Medical SA will be following its current price movements.

Auto-correlation

    
  -0.45  

Modest reverse predictability

Mercator Medical SA has modest reverse predictability. Overlapping area represents the amount of predictability between Mercator Medical time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mercator Medical price movement. The serial correlation of -0.45 indicates that just about 45.0% of current Mercator Medical price fluctuation can be explain by its past prices.
Correlation Coefficient-0.45
Spearman Rank Test-0.48
Residual Average0.0
Price Variance0.06
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, Mercator Medical SA reported net income of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Instruments & Supplies industry. The net income for all Germany stocks is 100.0% higher than that of the company.

Mercator Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mercator Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mercator Medical could also be used in its relative valuation, which is a method of valuing Mercator Medical by comparing valuation metrics of similar companies.
Mercator Medical is currently under evaluation in net income category among its peers.

About Mercator Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Mercator Medical SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mercator Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mercator Medical SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Mercator Stock

Mercator Medical financial ratios help investors to determine whether Mercator Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mercator with respect to the benefits of owning Mercator Medical security.